5566213780 · Partihandel med medicinsk utrustning och apoteksvaror · KISTA
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Astimex Pharma Aktiebolag reported a 23 % decline in net sales in 2025, to 56.2 MSEK. The operating margin declined from 43.6 % to 38.8 % in 2025. With an operating margin of 38.8 %, the company ranked at the 90th percentile among 579 companies in its industry. The company has reported a profit in three consecutive comparable fiscal periods (2023–2025).
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
56.2 MSEK
▼ −23%Net result
18 MSEK
▼ −31%Employees
6
Per the signatures in the annual report for the fiscal year ending 2025-06-30.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.